MEN2 encompasses three subtypes: type 2A (MEN2A), type 2B (MEN2B), and familial medullary thyroid carcinoma (FMTC), each associated with specific clinical features and germline RET mutations [79]. Here, RET is linked to multiple endocrine neoplasia type 2.